{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T18:31:25Z","timestamp":1781721085434,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12859-016-1433-7","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T14:44:00Z","timestamp":1483627440000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":321,"title":["KinMap: a web-based tool for interactive navigation through human kinome data"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4689-6354","authenticated-orcid":false,"given":"Sameh","family":"Eid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samo","family":"Turk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Volkamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Rippmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Fulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,5]]},"reference":[{"key":"1433_CR1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/9783527633470","volume-title":"Protein kinases as drug targets","author":"B Klebl","year":"2011","unstructured":"Klebl B, M\u00fcller G, Hamacher M. Protein kinases as drug targets. Weinheim: Wiley-VCH; 2011. p. 49."},{"issue":"5","key":"1433_CR2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","volume":"2","author":"BJ Druker","year":"1996","unstructured":"Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J, Lydon NB. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med. 1996;2(5):561\u20136.","journal-title":"Nat Med"},{"issue":"5600","key":"1433_CR3","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.1075762","volume":"298","author":"G Manning","year":"2002","unstructured":"Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science. 2002;298(5600):1912\u201334.","journal-title":"Science"},{"issue":"1","key":"1433_CR4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nbt1358","volume":"26","author":"MW Karaman","year":"2008","unstructured":"Karaman MW, Herrgard S, Treiber DK, Gallant P, Atteridge CE, Campbell BT, Chan KW, Ciceri P, Davis MI, Edeen PT, Faraoni R, Floyd M, Hunt JP, Lockhart DJ, Milanov ZV, Morrison MJ, Pallares G, Patel HK, Pritchard S, Wodicka LM, Zarrinkar PP. A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol. 2008;26(1):127\u201332.","journal-title":"Nat Biotechnol"},{"issue":"11","key":"1433_CR5","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nbt.2017","volume":"29","author":"T Anastassiadis","year":"2011","unstructured":"Anastassiadis T, Deacon SW, Devarajan K, Ma H, Peterson JR. Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol. 2011;29(11):1039\u201345.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"1433_CR6","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1021\/ci500624s","volume":"55","author":"A Volkamer","year":"2015","unstructured":"Volkamer A, Eid S, Turk S, Jaeger S, Rippmann F, Fulle S. Pocketome of human kinases: prioritizing the ATP binding sites of (yet) untapped protein kinases for drug discovery. J Chem Inf Model. 2015;55(3):538\u201349.","journal-title":"J Chem Inf Model"},{"issue":"1","key":"1433_CR7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1021\/ci200314j","volume":"52","author":"E Martin","year":"2012","unstructured":"Martin E, Mukherjee P. Kinase-kernel models: accurate in silico screening of 4 million compounds across the entire human kinome. J Chem Inf Model. 2012;52(1):156\u201370.","journal-title":"J Chem Inf Model"},{"key":"1433_CR8","unstructured":"DiscoveRx Corporation Home Page. http:\/\/www.discoverx.com\/ . Accessed 10 Apr 2016."},{"key":"1433_CR9","unstructured":"The human kinome Java component. http:\/\/tripod.nih.gov\/?p=260 . Accessed 10 Apr 2016."},{"key":"1433_CR10","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.7717\/peerj.126","volume":"1","author":"M Chartier","year":"2013","unstructured":"Chartier M, Ch\u00e9nard T, Barker J, Najmanovich R. Kinome Render: a stand-alone and web-accessible tool to annotate the human protein kinome tree. Peer J. 2013;1:e126.","journal-title":"Peer J"},{"issue":"1","key":"1433_CR11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The Protein Data Bank. Nucleic Acids Res. 2000;28(1):235\u201342.","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"1433_CR12","doi-asserted-by":"crossref","first-page":"D1083","DOI":"10.1093\/nar\/gkt1031","volume":"42","author":"AP Bento","year":"2014","unstructured":"Bento AP, Gaulton A, Hersey A, Bellis LJ, Chambers J, Davies M, Kr\u00fcger FA, Light Y, Mak L, McGlinchey S, Nowotka M, Papadatos G, Santos R, Overington JP. The ChEMBL bioactivity database: an update. Nucleic Acids Res. 2014;42(Database issue):D1083\u201390.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"1433_CR13","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nbt.1990","volume":"29","author":"MI Davis","year":"2011","unstructured":"Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol. 2011;29(11):1046\u201351.","journal-title":"Nat Biotechnol"},{"key":"1433_CR14","unstructured":"The CTTV Target Validation Platform. http:\/\/www.targetvalidation.org . Accessed 10 Apr 2016."},{"issue":"7","key":"1433_CR15","first-page":"2111","volume":"3","author":"NS Dhalla","year":"2010","unstructured":"Dhalla NS, M\u00fcller AL. Protein Kinases as Drug Development Targets for Heart Disease Therapy. Pharm. 2010;3(7):2111\u201345.","journal-title":"Pharm"},{"issue":"Database issue","key":"1433_CR16","doi-asserted-by":"crossref","first-page":"D204","DOI":"10.1093\/nar\/gku989","volume":"43","author":"UniProt Consortium","year":"2015","unstructured":"UniProt Consortium. UniProt: a hub for protein information. Nucleic Acids Res. 2015;43(Database issue):D204\u201312.","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"1433_CR17","doi-asserted-by":"crossref","first-page":"D1079","DOI":"10.1093\/nar\/gku1071","volume":"43","author":"KA Gray","year":"2015","unstructured":"Gray KA, Yates B, Seal RL, Wright MW, Bruford EA. Genenames.org: the HGNC resources in 2015. Nucleic Acids Res. 2015;43(Database issue):D1079\u201385.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1433_CR18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nbt.2786","volume":"32","author":"M Hay","year":"2014","unstructured":"Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J. Clinical development success rates for investigational drugs. Nat Biotechnol. 2014;32(1):40\u201351.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"1433_CR19","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1208\/s12248-012-9390-1","volume":"14","author":"TI Oprea","year":"2012","unstructured":"Oprea TI, Mestres J. Drug repurposing: far beyond new targets for old drugs. AAPS J. 2012;14(4):759\u201363.","journal-title":"AAPS J"},{"issue":"2","key":"1433_CR20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa060655","volume":"356","author":"B Escudier","year":"2007","unstructured":"Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, Desai AA, Rolland F, Demkow T, Hutson TE, Gore M, Freeman S, Schwartz B, Shan M, Simantov R, Bukowski RM, Group TS. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med. 2007;356(2):125\u201334.","journal-title":"N Engl J Med"},{"issue":"2","key":"1433_CR21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00003495-200969020-00006","volume":"69","author":"GM Keating","year":"2009","unstructured":"Keating GM, Santoro A. Sorafenib: a review of its use in advanced hepatocellular carcinoma. Drugs. 2009;69(2):223\u201340.","journal-title":"Drugs"},{"issue":"6","key":"1433_CR22","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1517\/13543780902980171","volume":"18","author":"HK Gan","year":"2009","unstructured":"Gan HK, Seruga B, Knox JJ. Sunitinib in solid tumors. Expert Opin Investig Drugs. 2009;18(6):821\u201334.","journal-title":"Expert Opin Investig Drugs"},{"issue":"6","key":"1433_CR23","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1210\/jc.2009-1923","volume":"95","author":"ME Cabanillas","year":"2010","unstructured":"Cabanillas ME, Waguespack SG, Bronstein Y, Williams MD, Feng L, Hernandez M, Lopez A, Sherman SI, Busaidy NL. Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the M. D. Anderson experience. J Clin Endocrinol Metab. 2010;95(6):2588\u201395.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1433_CR24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1530\/EJE-15-0930","volume":"174","author":"A Bikas","year":"2016","unstructured":"Bikas A, Kundra P, Desale S, Mete M, O\u2019Keefe K, Clark BG, Wray L, Gandhi R, Barett C, Jelinek JS, Wexler JA, Wartofsky L, Burman KD. Phase 2 clinical trial of sunitinib as adjunctive treatment in patients with advanced differentiated thyroid cancer. Eur J Endocrinol. 2016;174(3):373\u201380.","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"1433_CR25","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4161\/cbt.25191","volume":"14","author":"MY Al-Marrawi","year":"2013","unstructured":"Al-Marrawi MY, Saroya BS, Brennan MC, Yang Z, Dykes TM, El-Deiry WS. Off-label use of cetuximab plus sorafenib and panitumumab plus regorafenib to personalize therapy for a patient with V600E BRAF-mutant metastatic colon cancer. Cancer Biol Ther. 2013;14(8):703\u201310.","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"1433_CR26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000375483","volume":"8","author":"RB Moreira","year":"2015","unstructured":"Moreira RB, Peixoto RD, de Sousa Cruz MR. Clinical Response to Sorafenib in a Patient with Metastatic Colorectal Cancer and FLT3 Amplification. Case Rep Oncol. 2015;8(1):83\u20137.","journal-title":"Case Rep Oncol"},{"issue":"3","key":"1433_CR27","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1158\/0008-5472.CAN-13-2175","volume":"74","author":"YR Chin","year":"2014","unstructured":"Chin YR, Yoshida T, Marusyk A, Beck AH, Polyak K, Toker A. Targeting Akt3 signaling in triple-negative breast cancer. Cancer Res. 2014;74(3):964\u201373.","journal-title":"Cancer Res"},{"key":"1433_CR28","doi-asserted-by":"crossref","first-page":"703568","DOI":"10.1155\/2013\/703568","volume":"2013","author":"JY Tang","year":"2013","unstructured":"Tang JY, Lee JC, Hou MF, Wang CL, Chen CC, Huang HW, Chang HW. Alternative splicing for diseases, cancers, drugs, and databases. Sci World J. 2013;2013:703568.","journal-title":"Sci World J"},{"issue":"7132","key":"1433_CR29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature05610","volume":"446","author":"C Greenman","year":"2007","unstructured":"Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, Edkins S, O\u2019Meara S, Vastrik I, Schmidt EE, Avis T, Barthorpe S, Bhamra G, Buck G, Choudhury B, Clements J, Cole J, Dicks E, Forbes S, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jenkinson A, Jones D, Menzies A, Mironenko T, Perry J, Raine K, Richardson D, Shepherd R, Small A, Tofts C, Varian J, Webb T, West S, Widaa S, Yates A, Cahill DP, Louis DN, Goldstraw P, Nicholson AG, Brasseur F, Looijenga L, Weber BL, Chiew YE, DeFazio A, Greaves MF, Green AR, Campbell P, Birney E, Easton DF, Chenevix-Trench G, Tan MH, Khoo SK, Teh BT, Yuen ST, Leung SY, Wooster R, Futreal PA, Stratton MR. Patterns of somatic mutation in human cancer genomes. Nature. 2007;446(7132):153\u20138.","journal-title":"Nature"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-016-1433-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T01:04:54Z","timestamp":1749863094000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-016-1433-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,5]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1433"],"URL":"https:\/\/doi.org\/10.1186\/s12859-016-1433-7","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,5]]},"article-number":"16"}}